InvestSMART

Island Pharmaceuticals Limited (ASX: ILA) - Announcements

Current share price for ILA : $0.415 0.005 (1.19%)+

ASX company news and announcements for Island Pharmaceuticals Limited (ILA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Island Pharmaceuticals Limited (ILA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Island Pharmaceuticals Limited (ILA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Island Pharmaceuticals Limited (ILA)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$123 Application for quotation of securities - ILA 4 Dec 2024 8:20AM $0.170 $0.415 risen by 144.12%
$123 EGM (Spill Meeting) & Closing Date for Director Nominations 3 Dec 2024 8:19AM $0.185 $0.415 risen by 124.32%
$123 Scientific Advisory Board Change 2 Dec 2024 9:36AM $0.195 $0.415 risen by 112.82%
$123 Application for quotation of securities - ILA 27 Nov 2024 11:54AM $0.210 $0.415 risen by 97.62%
$123 Island Phase 2a readout investor briefing presentation 27 Nov 2024 9:13AM $0.165 $0.415 risen by 151.52%
$123 Island Phase 2a readout investor briefing 27 Nov 2024 9:13AM $0.165 $0.415 risen by 151.52%
$123 ISLA-101 shows anti-dengue activity in Phase 2a readout 27 Nov 2024 9:04AM $0.165 $0.415 risen by 151.52%
$123 Trading Halt 25 Nov 2024 9:17AM $0.165 $0.415 risen by 151.52%
$123 Receipt of R&D tax refund for FY2024 22 Nov 2024 9:47AM $0.165 $0.415 risen by 151.52%
$123 Initial Director's Interest Notice - PL 21 Nov 2024 8:13AM $0.165 $0.415 risen by 151.52%
$123 Final Director's Interest Notice x 2 21 Nov 2024 8:13AM $0.165 $0.415 risen by 151.52%
$123 Application for quotation of securities - ILA 20 Nov 2024 8:59AM $0.180 $0.415 risen by 130.56%
$123 Replacement - Results of AGM 19 Nov 2024 3:43PM $0.175 $0.415 risen by 137.14%
$123 Results of AGM 19 Nov 2024 11:12AM $0.180 $0.415 risen by 130.56%
$123 Annual General Meeting MD Presentation 19 Nov 2024 8:31AM $0.165 $0.415 risen by 151.52%
$123 Clinical trial progress update 18 Nov 2024 11:29AM $0.175 $0.415 risen by 137.14%
$123 Phillip Lynch appointed Executive Chairman 15 Nov 2024 8:19AM $0.180 $0.415 risen by 130.56%
$123 Application for quotation of securities - ILA 13 Nov 2024 9:35AM $0.160 $0.415 risen by 159.38%
$123 Investor Presentation 12 Nov 2024 8:20AM $0.120 $0.415 risen by 245.83%
$123 Board changes 11 Nov 2024 8:29AM $0.120 $0.415 risen by 245.83%
$123 Investor information session 7 Nov 2024 8:24AM $0.110 $0.415 risen by 277.27%
$123 Application for quotation of securities - ILA 6 Nov 2024 11:14AM $0.110 $0.415 risen by 277.27%
$123 Quarterly Activities & Cashflow Report 31 Oct 2024 8:20AM $0.125 $0.415 risen by 232%
$123 Application for quotation of securities - ILA 30 Oct 2024 8:42AM $0.125 $0.415 risen by 232%
$123 Application for quotation of securities - ILA 23 Oct 2024 8:48AM $0.145 $0.415 risen by 186.21%

176 - 200 of 441 results

Page 8 of 18

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.